ABVC BioPharma Inc (NASDAQ:ABVC) price on Wednesday, July 02, rose 28.10% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.1.
A look at the stock’s price movement, the close in the last trading session was $2.42, moving within a range at $2.38 and $3.1. The beta value (5-Year monthly) was 0.186. Turning to its 52-week performance, $2.70 and $0.40 were the 52-week high and 52-week low respectively. Overall, ABVC moved 101.30% over the past month.
ABVC BioPharma Inc’s market cap currently stands at around $52.65 million, with investors looking forward to this quarter’s earnings report slated for on 2023-May-15.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ABVC is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 0 recommend ABVC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ABVC’s current price about 56.62% and 102.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 75.81, while 7-day volatility ratio is 17.30% and 11.61% in the 30-day chart. Further, ABVC BioPharma Inc (ABVC) has a beta value of 0.25.
If we refocus on ABVC BioPharma Inc (NASDAQ:ABVC), historical trading data shows that trading volumes averaged 0.49 over the past 10 days and 406.71K over the past 3 months. The company’s latest data on shares outstanding shows there are 15.38 million shares.
The 14.33% of ABVC BioPharma Inc’s shares are in the hands of company insiders while institutional holders own 1.69% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.51 million on 2025-06-13, giving us a short ratio of 1.48. The data shows that as of 2025-06-13 short interest in ABVC BioPharma Inc (ABVC) stood at 357.0 of shares outstanding, with shares short rising to 0.44 million registered in 2025-05-15. Current price change has pushed the stock 300.52% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ABVC stock continues to rise going into the next quarter.
